All Stories

  1. Laxative use and acute kidney injury risk: Analysis of a Japanese hospital-based database

    Article • Journal of Pharmacology and Experimental Therapeutics, February 2026, Elsevier

    Dr Satoru Mitsuboshi

  2. Validation of diagnostic coding for chronic kidney disease using a Japanese hospital-based database

    Article • Clinical and Experimental Nephrology, January 2026, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  3. Association between use of lubiprostone and headache: A systematic review and meta‐analysis of randomized controlled trials

    Article • British Journal of Clinical Pharmacology, October 2025, Wiley

    Dr Satoru Mitsuboshi

  4. Comment on: Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalised patients with pneumonia: a nationwide retrospective cohort study

    Article • Journal of Antimicrobial Chemotherapy, July 2025, Oxford University Press (OUP)

    Dr Satoru Mitsuboshi

  5. Evaluation of antibiotic de-escalation based on the DASON criteria by pharmacist-led post-prescription review and feedback: A retrospective study in a medium-sized Japanese hospital

    Article • Journal of Infection and Chemotherapy, June 2025, Elsevier

    Dr Satoru Mitsuboshi

  6. Accuracy of Diagnostic Coding for Acute Kidney Injury in Japan—Analysis of a Japanese Hospital‐Based Database

    Article • Pharmacoepidemiology and Drug Safety, April 2025, Wiley

    Dr Satoru Mitsuboshi

  7. Enhancing result reliability by addressing potential confounding factors

    Article • Microbiology Spectrum, February 2025, ASM Journals

    Dr Satoru Mitsuboshi

  8. Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials

    Article • European Journal of Clinical Pharmacology, November 2024, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  9. Association between mineralocorticoid receptor antagonists and kidney harm: A systematic review and meta‐analysis of randomized controlled trials

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, November 2024, Wiley

    Dr Satoru Mitsuboshi

  10. Association between gastroprotective agents and acute kidney injury in patients receiving non‐steroidal anti‐inflammatory drugs: Analysis of a Japanese hospital‐based database

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, October 2024, Wiley

    Dr Satoru Mitsuboshi

  11. Concomitant use of lansoprazole and ceftriaxone is associated with an increased risk of ventricular arrhythmias and cardiac arrest in a large Japanese hospital database

    Article • Journal of Infection, August 2024, Elsevier

    Dr Satoru Mitsuboshi

  12. Association Between the Dose of Tofacitinib and Risk of Herpes Zoster in Patients With Rheumatoid Arthritis: Analysis of Japanese Adverse Drug Event Report Data

    Article • Cureus, June 2024, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  13. Association between roxadustat use and suppression of thyroid function: a systematic review and meta-analysis

    Article • Journal of Pharmaceutical Health Care and Sciences, June 2024, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  14. Individual dipeptidyl peptidase‐4 inhibitors and acute kidney injury in patients with type 2 diabetes: A systematic review and network meta‐analysis

    Article • Basic & Clinical Pharmacology & Toxicology, May 2024, Wiley

    Dr Satoru Mitsuboshi

  15. Association between use of romosozumab and cardiovascular events: analysis of the Japanese Adverse Event Report database

    Article • January 2024, Authorea, Inc.

    Dr Satoru Mitsuboshi

  16. Influence of vasopressin receptor antagonists on triple‐whammy acute kidney injury: A VigiBase analysis

    Article • British Journal of Clinical Pharmacology, December 2023, Wiley

    Dr Satoru Mitsuboshi

  17. Effect of cytochrome P450 1A2 inhibitors on rhabdomyolysis in patients on clozapine: Analysis using the US Food and Drug Administration's Adverse Event Reporting System

    Article • Schizophrenia Research, December 2023, Elsevier

    Dr Satoru Mitsuboshi

  18. Comparison of different sustained‐release opioids and acute respiratory conditions in patients with cancer and chronic kidney disease

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, November 2023, Wiley

    Dr Satoru Mitsuboshi

  19. Reply to: Comments on Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics

    Article • International Journal of Cancer, October 2023, Wiley

    Dr Satoru Mitsuboshi

  20. Urate‐Lowering Drugs And Muscle Injury: A Systematic Review and Network Meta‐Analysis

    Article • The Journal of Clinical Pharmacology, October 2023, Wiley

    Dr Satoru Mitsuboshi

  21. Reply to: Comment: Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting System

    Article • The Journal of Clinical Pharmacology, August 2023, Wiley

    Dr Satoru Mitsuboshi

  22. Association between misoprostol and non‐steroidal anti‐inflammatory drug‐induced kidney injury: a systematic review and meta‐analysis

    Article • British Journal of Clinical Pharmacology, June 2023, Wiley

    Dr Satoru Mitsuboshi

  23. Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics

    Article • International Journal of Cancer, June 2023, Wiley

    Dr Satoru Mitsuboshi

  24. Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting System

    Article • The Journal of Clinical Pharmacology, May 2023, Wiley

    Dr Satoru Mitsuboshi

  25. Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase)

    Article • Drug Safety, April 2023, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  26. Dysautonomia associated with immune checkpoint inhibitors

    Article • Deutsche Zeitschrift für Nervenheilkunde, March 2023, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  27. Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional Databases

    Article • Annals of Pharmacotherapy, February 2023, SAGE Publications

    Dr Satoru Mitsuboshi

  28. Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor

    Article • European Journal of Cancer, February 2023, Elsevier

    Dr Satoru Mitsuboshi

  29. Association between use of febuxostat and muscle injury: A disproportionality analysis and meta‐analysis of randomized controlled trials

    Article • British Journal of Clinical Pharmacology, January 2023, Wiley

    Dr Satoru Mitsuboshi

  30. Evaluation of Risk of Cardiac or Cerebrovascular Events in Romosozumab Users Focusing on Comorbidities: Analysis of the Japanese Adverse Drug Event Report Database

    Article • Journal of Pharmacy Technology, December 2022, SAGE Publications

    Dr Satoru Mitsuboshi

  31. Characterization of Immune Checkpoint Inhibitor–Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System

    Article • The Journal of Clinical Pharmacology, December 2022, Wiley

    Dr Satoru Mitsuboshi

  32. Association between Distigmine-induced Adverse Events and Serum Butyrylcholinesterase Level: A Multicenter Retrospective Study

    Article • YAKUGAKU ZASSHI, September 2022, Pharmaceutical Society of Japan

    Dr Satoru Mitsuboshi

  33. Evaluation of Preoperative Risk Factors for Sugammadex‐Induced Anaphylaxis: Analysis of the Japanese Adverse Drug Event Report Database

    Article • The Journal of Clinical Pharmacology, July 2022, Wiley

    Dr Satoru Mitsuboshi

  34. Risks of serious adverse events and kidney injury in patients treated with ibandronate: A systematic review and meta‐analysis

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, June 2022, Wiley

    Dr Satoru Mitsuboshi

  35. Association Between Antiosteoporotic Drugs and Risk of Acute Kidney Injury: A Cross‐Sectional Study Using Disproportional Analysis and a Pharmacovigilance Database

    Article • The Journal of Clinical Pharmacology, June 2022, Wiley

    Dr Satoru Mitsuboshi

  36. Analysis of the frequency of ceftriaxone-induced encephalopathy using the Japanese Adverse Drug Event Report database

    Article • International Journal of Clinical Pharmacy, April 2022, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  37. Atenolol and mortality events in patients with chronic kidney disease: Analysis of data from the Japanese Adverse Drug Event Report database

    Article • Basic & Clinical Pharmacology & Toxicology, February 2022, Wiley

    Dr Satoru Mitsuboshi

  38. Risk of Pregabalin‐Induced Hypoglycemia: Analysis of the Japanese Adverse Drug Event Report Database

    Article • The Journal of Clinical Pharmacology, January 2022, Wiley

    Dr Satoru Mitsuboshi

  39. Association Between the Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Drug‐Induced Acute Kidney Injury: Analysis of 2 Databases

    Article • The Journal of Clinical Pharmacology, January 2022, Wiley

    Dr Satoru Mitsuboshi

  40. Risk of kidney injury in patients on concomitant oral vancomycin and piperacillin‐tazobactam: Analysis of the pharmacovigilance database in Japan

    Article • Basic & Clinical Pharmacology & Toxicology, November 2021, Wiley

    Dr Satoru Mitsuboshi

  41. Risk of Hematologic Events With Coadministration of Methotrexate and the Breast Cancer Resistance Protein Inhibitor Febuxostat

    Article • Annals of Pharmacotherapy, November 2021, SAGE Publications

    Dr Satoru Mitsuboshi

  42. Inappropriate use of ozone generators and their sales status: questionnaire survey of healthcare providers and investigation of online sales

    Article • Journal of Hospital Infection, November 2021, Elsevier

    Dr Satoru Mitsuboshi

  43. Association Between Steroid Use and Nephropathy in Patients Who Were Administered a Proton Pump Inhibitor: Analysis of the Japanese Adverse Event Report Database

    Article • The Journal of Clinical Pharmacology, October 2021, Wiley

    Dr Satoru Mitsuboshi

  44. Fluoropyridmidine use and hypertriglyceridemia among Japanese patients: analysis of adverse event database

    Article • International Journal of Clinical Pharmacy, September 2021, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  45. Risk of muscle toxicity events for daptomycin with and without statins: Analysis of the Japanese Adverse Event Report database

    Article • Basic & Clinical Pharmacology & Toxicology, June 2021, Wiley

    Dr Satoru Mitsuboshi

  46. Amantadine and Fatal Events in Patients With Chronic Kidney Disease: Analysis of the Japanese Adverse Event Report Database

    Article • Annals of Pharmacotherapy, June 2021, SAGE Publications

    Dr Satoru Mitsuboshi

  47. Does Quinolone- or Macrolide-Resistant <i>Streptococcus agalactiae</i> Bacteremia Affect Patient Outcome? A Multicenter Cohort Study

    Article • Japanese Journal of Infectious Diseases, May 2021, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Satoru Mitsuboshi

  48. Association Between Baclofen and Respiratory Depression in Patients With Chronic Kidney Disease

    Article • The Journal of Clinical Pharmacology, March 2021, Wiley

    Dr Satoru Mitsuboshi

  49. Association between extended-spectrum β-lactamase–producing Escherichia coli and oral third-generation cephalosporins

    Article • Infection Control, January 2021, Cambridge University Press

    Dr Satoru Mitsuboshi

  50. Differences in risk factors for anticoagulant‐related nephropathy between warfarin and direct oral anticoagulants: Analysis of the Japanese adverse drug event report database

    Article • British Journal of Clinical Pharmacology, December 2020, Wiley

    Dr Satoru Mitsuboshi

  51. ARN risk of warfarin and DOACs

    Article • British Journal of Clinical Pharmacology, November 2020, Wiley

    Dr Satoru Mitsuboshi

  52. Regional outbreak of methicillin-resistant Staphylococcus aureus ST2725-t1784 in rural Japan

    Article • Infection Control, November 2020, Cambridge University Press

    Dr Satoru Mitsuboshi

  53. Concomitant Use of Acetaminophen and Aspirin Increases Risk of Kidney Injury: Analysis of the Japanese Adverse Drug Event Report Database

    Article • The Journal of Clinical Pharmacology, October 2020, Wiley

    Dr Satoru Mitsuboshi

  54. Inappropriate sales of hypochlorous acid solution in Japan: An online investigation

    Article • Infection Control, October 2020, Cambridge University Press

    Dr Satoru Mitsuboshi

  55. Effect of Patient Age, Dose, and Chronic Kidney Disease on the Risk of Adverse Reactions to Distigmine

    Article • Biological and Pharmaceutical Bulletin, August 2020, Pharmaceutical Society of Japan

    Dr Satoru Mitsuboshi

  56. Advanced Age is not a Risk Factor for Mortality in Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Organisms: a Multicenter Cohort Study

    Article • Japanese Journal of Infectious Diseases, July 2020, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Satoru Mitsuboshi

  57. Is Concomitant Therapy with Acetaminophen and Low-dose Aspirin a Risk Factor for CKD Progression? A 6-Year Cohort Study

    Article • YAKUGAKU ZASSHI, July 2020, Pharmaceutical Society of Japan

    Dr Satoru Mitsuboshi

  58. Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata, Japan

    Article • Journal of Oncology Pharmacy Practice, May 2020, SAGE Publications

    Dr Satoru Mitsuboshi

  59. Stability of probiotics with antibiotics via gastric tube by simple suspension method: An in vitro study

    Article • Journal of Infection and Chemotherapy, October 2019, Elsevier

    Dr Satoru Mitsuboshi

  60. Does Quick Sepsis-Related Organ Failure Assessment Suggest the Use of Initial Empirical Carbapenem Therapy in Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Bacteria? :A Multicenter Case-Control Study

    Article • Japanese Journal of Infectious Diseases, March 2019, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Satoru Mitsuboshi

  61. Impact of alcohol-based hand sanitizers, antibiotic consumption, and other measures on detection rates of antibiotic-resistant bacteria in rural Japanese hospitals

    Article • Journal of Infection and Chemotherapy, September 2018, Elsevier

    Dr Satoru Mitsuboshi

  62. Antimicrobial Therapeutic Drug Monitoring Performance Rate in Niigata: Evaluation between Performance Rate and Relevant Factors

    Article • Japanese Journal of Infection Prevention and Control, March 2018, Japanese Society of Environmental Infections

    Dr Satoru Mitsuboshi

  63. Clinical advantage and tolerability of ibandronate in hemodialysis patients: a retrospective study

    Article • Renal Replacement Therapy, January 2018, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  64. Low Continuity Rate of Sucroferric Oxyhydroxide among Japanese Hemodialysis Patients with High Phosphate Binder Pill Burden

    Article • YAKUGAKU ZASSHI, January 2018, Pharmaceutical Society of Japan

    Dr Satoru Mitsuboshi

  65. Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report

    Article • Journal of Oncology Pharmacy Practice, July 2017, SAGE Publications

    Dr Satoru Mitsuboshi

  66. Clinical Advantage of Topiroxostat

    Article • Biological and Pharmaceutical Bulletin, January 2017, Pharmaceutical Society of Japan

    Dr Satoru Mitsuboshi

  67. Evaluation of Combination Effect of an Alcohol-based Hand Rub: Introducing Portable Bottles and Providing the Feedback

    Article • Japanese Journal of Infection Prevention and Control, January 2017, Japanese Society of Environmental Infections

    Dr Satoru Mitsuboshi

  68. <b>Evaluation of Drug Release from a Bisoprolol Patch Preparation and its Pharmacokinetics after Eight-hour Application </b>

    Article • Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, January 2017, Japanese Society of Clinical Pharmacology and Therapeutics

    Dr Satoru Mitsuboshi

  69. No effect of protein binding ratio of levofloxacin in hemodialysis patients

    Article • Renal Replacement Therapy, July 2016, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  70. Risk Factor of Isolation Rate of MRSA: Evaluation of 5 Hospitals in Niigata

    Article • Japanese Journal of Infection Prevention and Control, January 2016, Japanese Society of Environmental Infections

    Dr Satoru Mitsuboshi

  71. Switching from allopurinol to febuxostat: efficacy and tolerability in hemodialysis patients.

    Article • Journal of Pharmaceutical Health Care and Sciences, October 2015, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  72. Studies on the effects of brown rice diet on lipid metabolism in cholesterolemia

    Article • Journal for the Integrated Study of Dietary Habits, January 2014, Japanese Association for the Integrated Study of Dietary Habits

    Dr Satoru Mitsuboshi